Zenas Biopharma Inc (ZBIO)

Feb 06, 2025

Zenas BioPharma Targets Key 2025 Milestones For Obexelimab In Autoimmune Diseases - BERNAMA

Feb 06, 2025

Feb 06, 2025

ZENAS BIOPHARMA TARGETS KEY 2025 MILESTONES FOR OBEXELIMAB IN AUTOIMMUNE DISEASES - BERNAMA

Feb 06, 2025

Feb 06, 2025

ZENAS BIOPHARMA ANNOUNCES KEY 2024 ACCOMPLISHMENTS AND 2025 BUSINESS OBJECTIVES TO SUPPORT THE GLOBAL DEVELOPMENT AND COMMERCIALIZATION OF THERAPIES FOR AUTOIMMUNE DISEASES - BERNAMA

Feb 06, 2025

Feb 05, 2025

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives - Marketscreener.com

Feb 05, 2025

Feb 05, 2025

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 - GlobeNewswire

Feb 05, 2025

Feb 05, 2025

Wolfe Research Initiates Coverage of Zenas BioPharma (ZBIO) with Outperform Recommendation - MSN

Feb 05, 2025

Feb 04, 2025

Zenas BioPharma initiated with an Outperform at Wolfe Research - MSN

Feb 04, 2025

Feb 04, 2025

Wolfe Research Initiates Coverage on Zenas BioPharma With Outperform Rating, $19 Price Target - Marketscreener.com

Feb 04, 2025

Feb 03, 2025

Zenas Biopharma To Present At Guggenheim SMID Cap Biotech Conference On Feb 5 - BERNAMA

Feb 03, 2025

Jan 31, 2025

ZENAS BIOPHARMA TO PRESENT AT THE GUGGENHEIM SMID CAP BIOTECH CONFERENCE - BERNAMA

Jan 31, 2025

Jan 28, 2025

Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference - The Manila Times

Jan 28, 2025

Jan 28, 2025

Zenas BioPharma Takes Center Stage: Key Revelations Expected at Major Biotech Summit - StockTitan

Jan 28, 2025

Jan 22, 2025

Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Jan 22, 2025

Jan 01, 2025

Biotech IPO Shares 2025 Climb In Trading Debuts After Deals Upsized - Browvopetshop

Jan 01, 2025

Dec 17, 2024

Zenas BioPharma initiated with a Buy at H.C. Wainwright - Yahoo Finance

Dec 17, 2024

Dec 16, 2024

HC Wainwright & Co. Initiates Coverage of Zenas BioPharma (ZBIO) with Buy Recommendation - MSN

Dec 16, 2024

Dec 16, 2024

This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 16, 2024

Dec 16, 2024

H.C. Wainwright starts Zenas stock with Buy rating, eyes Obexelimab’s role in autoimmune treatment - Investing.com Australia

Dec 16, 2024

Dec 13, 2024

Guggenheim maintains buy on ZBIO shares, sees strong drug potential By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 12, 2024

Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley - Yahoo Finance

Dec 12, 2024

Dec 04, 2024

Zenas BioPharma CEO Leon O. Moulder Jr. purchases $718,100 in stock - Investing.com

Dec 04, 2024

Nov 21, 2024

Zenas BioPharma CEO Leon O. Moulder Jr. acquires shares worth $148,925 By Investing.com - Investing.com South Africa

Nov 21, 2024

Nov 20, 2024

Zenas BioPharma CEO Leon O. Moulder Jr. acquires shares worth $148,925 - Investing.com

Nov 20, 2024

Nov 14, 2024

Zenas BioPharma Inc. (ZBIO) Quarterly 10-Q Report - Quartz

Nov 14, 2024

Nov 13, 2024

FMR LLC Acquires New Stake in Zenas BioPharma Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Zenas BioPharma Raises $259M in IPO, Advances Phase 3 Trial Amid Growing R&D Investment | ZBIO Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Zenas BioPharma Completes Targeted Enrollment of the Phase - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Zenas BioPharma Hits Milestone: Completes Enrollment in Largest-Ever IgG4-RD Trial | ZBIO Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Zenas BioPharma To Attend Upcoming Healthcare Investor Conferences - BERNAMA

Nov 08, 2024

Nov 07, 2024

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences - BERNAMA

Nov 07, 2024

Nov 07, 2024

TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Arm Holdings Plc ADR (ARM-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 07, 2024

Oct 22, 2024

Zenas Bio: Recent IPO With Late-Stage Candidate (NASDAQ:ZBIO) - Seeking Alpha

Oct 22, 2024

Oct 16, 2024

Biopharma financing drops in Q3, but is outpacing last two years - BioWorld Online

Oct 16, 2024

Oct 08, 2024

Zenas started at buy by four banks on lead drug potential (NASDAQ:ZBIO) - Seeking Alpha

Oct 08, 2024

Oct 08, 2024

Zenas stock backed by Guggenheim on strong outlook for lead drug obexelimab - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Morgan Stanley bullish on Zenas Biopharma stock as obexelimab trials gain momentum - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Citi sees upside in Zenas Biopharma stock as obexelimab progresses in key trials - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Jefferies bullish on Zenas stock as obexelimab advances in autoimmune trials - Investing.com Canada

Oct 08, 2024

Oct 04, 2024

Biopharma financings surge to $86.2B in 2024, with $8.7B in September - BioWorld Online

Oct 04, 2024

Oct 01, 2024

Halda appoints new chief executive - The Pharma Letter

Oct 01, 2024

Sep 27, 2024

IgG4-related Disease Market to Show Remarkable Growth Trends - openPR

Sep 27, 2024

Sep 22, 2024

Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.

Sep 22, 2024

Sep 21, 2024

Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN

Sep 21, 2024

Sep 21, 2024

Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com India

Sep 21, 2024